Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRACLEER
- Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
- Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1
- Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
- Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects
- the Effect of Tracleer on Tourniquet-associated Hypertension
- Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
- Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study
- Endothelin Receptor Function and Acute Stress
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
- ET-blockade and Exercise-induced Vascular Adaptations in T2DM
- ET-blockade and Exercise Induced Blood Flow in T2DM
- Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease
- Bosentan Therapy in Children With Functional Single Ventricle
- Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
- Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin
- Persistent Pulmonary Hypertension of the Newborn
- Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
- Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)
- Endothelin Blockade in Patients With Single Ventricle Physiology
- Early Therapy of Pulmonary Arterial Hypertension
- Insulin Resistance in Pulmonary Arterial Hypertension
- Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea
- Bosentan Use in Patients With Diabetic Nephropathy
- Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
- Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
- Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
- Pulmonary Artery Remodelling With Bosentan
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
- Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- Bosentan in Treatment of Pulmonary Arterial Hypertension
- Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia
- Treatment of Supine Hypertension in Autonomic Failure
- Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
- The Effect of Tracleer® on Male Fertility
- Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension
- Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Clinical trials list
click for details